Scantox is a leading Nordic preclinical GLP-accredited CRO specializing in pharmacology and regulatory toxicology. With headquarters in Denmark, where the company was established in 1977, Scantox also has subsidiaries in Sweden. Trusted by pharmaceutical, biotech, and medical device industries, Scantox offers product development services based on solid data and the highest scientific standards.

Their core business includes exploratory and efficacy studies, PK studies, general toxicology, wound healing, vaccines, GLP and GMP compliance, and more. Each location provides unique specialties like infectious disease models, advanced imaging, oncology models, and metabolic disorders. Scantox is your go-to partner for comprehensive services in the drug development process, from in vitro and in vivo studies in early discovery to preclinical trials testing drug efficacy and safety.

As a GLP-accredited company, Scantox ensures the quality and integrity of test data necessary for non-clinical studies. Building on over 30 years of expertise, Scantox is highly respected in the medical and pharmaceutical industries and leads in research with Göttingen Minipigs. With a global reach and a commitment to excellence, Scantox is your trusted partner in preclinical research